Global Gum Grafting Market Size, Share, Forecast Report, 2020-2027

Gum grafting or gingival grafting is the surgical procedure in which the gum tissue is grafted. The aim may be to cover exposed root surfaces or merely to augment the band of keratinized tissue. Gum grafting is widely used in the treatment of soft tissue alveolar ridge defects involving loss of buccal control, soft tissue augmentation around implants and many more. The global gum grafting market is driven by rising number of patients suffering from dental problems which include tooth decay, gum disease, oral cancer, tooth erosion, and tooth sensitivity. Other drivers include increasing awareness about dental hygiene. In addition to these, rising incidence of accidents, geriatric population, poor diet, and introduction of new gum grafts products have fuelled the growth of this market. However, high cost of treatment and poor reimbursement policies may hinder this market’s growth.
Segmentation

The global gum grafting market is segmented on the basis of applications, types, end users and regions. On the basis of application, the market is further segmented into root coverage, ridge augmentation, augmentation around implants, reduced sensitivity, improved appearance, gum health, and others. On the basis of types, the market is classified into connective-tissue, subepithelial connective tissue graft, free gingival grafts, pedicle grafts, and alloderm. On the basis of end users, the market is categorised into dentists, hospitals, and others.
Key players

Some of the major players of this market are BioHorizons IPH, Inc (UK), Floss Locations (Germany), Dr. Fresh LLC (US), Colgate-Palmolive Company (US), GlaxoSmithKline plc (UK), 3M Company (US), Ultradent Products Inc. (US), Sunstar Suisse S.A. (UK) and PatientPop.Inc (US)